Private Equity Firm Profile
L Capital Partners’ most common sectors for investment arelife science (25%) and medical products (25%) . The Firm’s most common investment types include venture (88%) and growth capital (7%). In total, L Capital Partners has invested in 10 US states and 2 different countries. Its largest (disclosed) acquisition occurred in 2007 when it acquired Locus Pharmaceuticals for $30M.
The Firm’s most common exit type is trade sale (72%). L Capital Partners’ largest (disclosed) exit occurred in 2008 when it sold Protez Pharmaceuticals for $400M.
Join Mergr to view L Capital Partners’ full profile and discover more small private equity firm investors just like it.
M&A Summary
-
M&A Total Activity23
- M&A Buy Activity16
- M&A Sell Activity7
- Total Sectors Invested 10
- Total Countries Invested 2
- M&A Buy/Sell Connections 12
- M&A Advisors 1
Unlimited Searches
